粉碎瑞卢片:在家庭模拟实验中评估粉末和活性成分的损失
相关实验视频
Updated: Jul 19, 2025

05:44
Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
1.6K
Antonella Casiraghi1, Andrea Gentile1, Ivan Marjanovic2
1Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.
Amyotrophic lateral sclerosis & frontotemporal degeneration
|August 16, 2023
概括
对于肌缩性侧面硬化症 (ALS) 患者,在家中粉碎瑞卢片会导致大量的粉末和活性成分 (API) 损失. 这凸显了在家庭环境中改变药物的风险.
科学领域:
- 制药科学 制药科学
- 神经学 神经学
背景情况:
- 患有肌缩性侧面硬化症 (ALS) 的患者经常经历消化不良,导致压碎口服药物的做法.
- 粉碎药物可能会改变其完整性和有效性,在家庭环境中对riluzole的后果尚不清楚.
研究的目的:
- 模拟和评估粉末和活性成分 (API) 的损失,当使用常见的家庭方法粉碎riluzole片.
- 在模仿患者家庭环境的条件下量化药物损失的程度.
主要方法:
- 一个模拟实验,涉及15名志愿者使用肉类软化器 (方法A) 或两个匙 (方法B) 粉碎riluzole片.
- 用高性能液态染色学 (HPLC) 测量粉末损失的重量差异和API含量分析.
主要成果:
- 观察到平均粉末损失为6.27% (13±13毫克).
- 具有统计学意义的8.53% (4.27±4.50毫克) 的平均API损失与粉末损失直接相关.
- 两种测试的粉碎方法都导致了大量和显著的API损失.
结论:
- 在模拟的家庭环境中粉碎瑞卢片导致粉末和API的显著损失.
- 这些发现强调了在家中改变药物配方的风险,并表明需要为ALS患者提供替代配方.
- 医疗保健提供者在向患有吞困难的患者提供建议时应考虑这些风险.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
154
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
154
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
334
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
334
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
104
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
104

